Boryung Corporation (KRX:003850)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,030.00
-10.00 (-0.11%)
At close: Dec 5, 2025
-10.77%
Market Cap 762.86B
Revenue (ttm) 1.03T
Net Income (ttm) 56.45B
Shares Out 84.48M
EPS (ttm) 688.80
PE Ratio 13.11
Forward PE 20.93
Dividend 100.00 (1.11%)
Ex-Dividend Date Dec 29, 2025
Volume 123,196
Average Volume 232,794
Open 9,060.00
Previous Close 9,040.00
Day's Range 8,910.00 - 9,100.00
52-Week Range 7,680.00 - 11,100.00
Beta 0.30
RSI 59.74
Earnings Date Nov 13, 2025

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1957
Employees 1,027
Stock Exchange Korea Stock Exchange
Ticker Symbol 003850
Full Company Profile

Financial Performance

In 2024, Boryung's revenue was 1.02 trillion, an increase of 18.32% compared to the previous year's 859.63 billion. Earnings were 69.63 billion, an increase of 73.20%.

Financial Statements

News

There is no news available yet.